Cream plus light therapy for mild to moderate psoriasis
Part of Skin clinical trials.
This study tests whether adding a special moisturizer, Ceramol PSOR cream, to standard narrowband UVB light therapy helps reduce psoriasis symptoms like itching and dryness. It is for people with mild to moderate plaque psoriasis who are already planning to have light therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have mild or moderate plaque psoriasis on your body (covering 3–10% of your skin, not including palms and soles).
- You are about to start narrowband UVB light therapy as part of your routine care.
- You have bothersome psoriasis symptoms like itching, burning, dryness, or tightness (rated at least 3 on a 10-point scale).
- You are willing to use only this cream as your daily moisturizer during the light therapy course.
- You are not currently taking oral or topical psoriasis medications, or you stopped topical ones at least a week before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a cream made from a natural plant compound (coumarin) to see if it can help treat plaque psoriasis. If you have mild-to-moderate psoriasis and haven't used certain other treatments recently, this trial may be an option for you.
This study tests whether narrowband ultraviolet B (UVB) light given three times a week for 12 weeks improves moderate-to-severe plaque psoriasis. It is an “open-label” pilot, meaning everyone gets the UVB treatment and researchers track how your skin responds.
This study tests an herbal cream made from Ciplukan (a plant) on plaque psoriasis. If you are an adult with mild-to-moderate psoriasis and are not already using other treatments, this trial may help find a gentler option.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
This trial tests a new cream form of apremilast, a medicine usually taken as a pill, for people with plaque psoriasis covering less than 10% of their body. The goal is to see if the cream is safe and effective in reducing psoriasis symptoms.
This study compares two ways to treat psoriasis on the palms of your hands and soles of your feet. Half of the participants will get a special laser treatment along with a steroid cream, while the other half will get only the cream, to see which approach works better.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.